These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14311922)

  • 41. [Clinical use of a new cardioactive glycoside: proscillaridin A].
    Tronconi L; Storti D
    Minerva Med; 1966 May; 57(43 Suppl):2011-7. PubMed ID: 5944829
    [No Abstract]   [Full Text] [Related]  

  • 42. [Intravenous proscillaridin A in cardiotonic therapy of the senile heart].
    Massoni G
    G Gerontol; 1968 Sep; 16(9):975-8. PubMed ID: 5754030
    [No Abstract]   [Full Text] [Related]  

  • 43. [Contribution to the quantitative and qual-itative study on the glycoside proscillaridin].
    Wülfing von der Heyden D
    Med Welt; 1969 Mar; 13():738-43. PubMed ID: 5784356
    [No Abstract]   [Full Text] [Related]  

  • 44. [Metabolic turnover and effect of cardiac glycosides. I. Determination of blood levels and of the ventricular ejection index and of R-I time derivated from apex cardiogram after intravenous injection of acetyl-digitoxin or proscillaridin A-H3 in normal subjects].
    Carbonin PU; Zecchi P; Antico L; Barletta A; Guerrera G; Gambassi G
    Minerva Cardioangiol; 1969 Nov; 17(11):929-41. PubMed ID: 5404821
    [No Abstract]   [Full Text] [Related]  

  • 45. [Influencing the cardiotonic effect of proscillaridin by verapamil].
    Manns KJ
    Med Klin; 1969 Oct; 64(44):2022-7. PubMed ID: 5370836
    [No Abstract]   [Full Text] [Related]  

  • 46. [Evaluation by the polygraphic method of the cardiokinetic action of a new glycoside isolated from scilla (proscillaridin A)].
    Battaglia A; Carli G; Gatto PL
    Minerva Med; 1966 May; 57(43 Suppl):1974-7. PubMed ID: 5943254
    [No Abstract]   [Full Text] [Related]  

  • 47. The bioavailability of methylepoxyproscillaridin (P35): a new semisynthetic cardiac glycoside.
    Bonelli J; Waginger W; Gazo F
    Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):297-9. PubMed ID: 3410606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Acetates of proscillaridin].
    Kubinyi H; Steidle W; Görlich B
    Arch Pharm Ber Dtsch Pharm Ges; 1971 May; 304(5):380-7. PubMed ID: 5284164
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical and physiopathological observations on the treatment of chronic cor pulmonale with an association of theophylline and proscillaridin A].
    Cavallaro GF
    Minerva Med; 1970 Feb; 61(15):669-79. PubMed ID: 5461420
    [No Abstract]   [Full Text] [Related]  

  • 50. [Action of oral proscillaridin treatment in various forms of heart insufficiency].
    Muth HW; Weyer H
    Med Welt; 1965 Dec; 51():2883-6. PubMed ID: 5884860
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical observations on the use of a new cardioactive glycoside: proscillaridin A].
    Martinetti L; Lai G
    Minerva Med; 1966 May; 57(43 Suppl):1994-9. PubMed ID: 5943258
    [No Abstract]   [Full Text] [Related]  

  • 52. [Proscillaridin A in some senile heart diseases. Preliminary clinico-therapeutic observations].
    Guerricchio G; Basile F; Tantalo L
    Minerva Med; 1966 May; 57(43 Suppl):1982-90. PubMed ID: 5943256
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical evaluation of Proscillaridin A, a glycoside of Scilla maritima].
    Kedra M; Kedrowa S
    Pol Tyg Lek; 1968 May; 23(19):714-6. PubMed ID: 4876207
    [No Abstract]   [Full Text] [Related]  

  • 54. [Standardized prescription glycoside: results of prescription analysis and clinical observations (glycoside intoxication)].
    Jordan D; Junge N; Schröder K; Schulz K; Spangenberg K; Wüstenberg PW
    Z Arztl Fortbild (Jena); 1975 Oct; 69(19):1017-21. PubMed ID: 1210392
    [No Abstract]   [Full Text] [Related]  

  • 55. [The clinical use of a new cardioactive glycoside: proscillaridin A].
    Maiorano G; Arbore S
    Minerva Med; 1967 Dec; 58(96):4243-6. PubMed ID: 6083285
    [No Abstract]   [Full Text] [Related]  

  • 56. [Research on a new cardioactive glycoside in clinical practice: proscillaridin A].
    Meschino S; Meoni S
    Minerva Med; 1966 May; 57(43 Suppl):2000-4. PubMed ID: 5943259
    [No Abstract]   [Full Text] [Related]  

  • 57. [On some aspects of occupational pathology in workers engaged in the manufacture of proscillaridin A].
    Tomasini M; Nava C
    Med Lav; 1970 Nov; 61(11):594-8. PubMed ID: 4251524
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effects of proscillaridin A on the duration of phases of ventricular systole and on normal heart rate].
    Brat A; Berni G; Fantini F
    Riv Crit Clin Med; 1965 Dec; 65(6):573-84. PubMed ID: 5869412
    [No Abstract]   [Full Text] [Related]  

  • 59. [Contribution to the konwledge of some effects of proscillaridin on the cardiovascular system. Electrocardiographic and radiocardiographic research].
    Sorrentino F; Musco A; Cascone O; Modica G
    Clin Ter; 1966 Jul; 38(1):39-48. PubMed ID: 5990470
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical use of a new cardioactive glycoside: proscillaridin A. Case studies].
    Pagliara R
    Minerva Med; 1967 Dec; 58(96):4296-301. PubMed ID: 6081717
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.